|
FPGT expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.92330000037266E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.837060E-04 |
| Normal-vs-Stage2 |
1.654440E-01 |
| Normal-vs-Stage3 |
1.33930000001392E-06 |
| Normal-vs-Stage4 |
2.22340001965193E-09 |
| Stage1-vs-Stage2 |
7.268400E-01 |
| Stage1-vs-Stage3 |
3.032100E-02 |
| Stage1-vs-Stage4 |
1.100780E-03 |
| Stage2-vs-Stage3 |
1.582190E-01 |
| Stage2-vs-Stage4 |
5.833700E-02 |
| Stage3-vs-Stage4 |
4.661400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.93890000014186E-07 |
| Normal-vs-AfricanAmerican |
3.30599999998071E-06 |
| Normal-vs-Asian |
4.790300E-02 |
| Caucasian-vs-AfricanAmerican |
1.384230E-01 |
| Caucasian-vs-Asian |
9.485400E-01 |
| AfricanAmerican-vs-Asian |
6.121800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.76380000499665E-08 |
| Normal-vs-Female |
9.009300E-04 |
| Male-vs-Female |
7.086100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.991300E-04 |
| Normal-vs-Age(41-60Yrs) |
5.61119999999971E-05 |
| Normal-vs-Age(61-80Yrs) |
1.35859999994548E-06 |
| Normal-vs-Age(81-100Yrs) |
2.295600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.082800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.043600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.286000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.984400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.568400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.745800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.152800E-01 |
| Normal-vs-Grade 2 |
8.875400E-03 |
| Normal-vs-Grade 3 |
3.2686000017712E-08 |
| Normal-vs-Grade 4 |
2.04192218689059E-12 |
| Grade 1-vs-Grade 2 |
2.438800E-01 |
| Grade 1-vs-Grade 3 |
3.097500E-02 |
| Grade 1-vs-Grade 4 |
1.448150E-04 |
| Grade 2-vs-Grade 3 |
1.771530E-02 |
| Grade 2-vs-Grade 4 |
4.73800000011515E-07 |
| Grade 3-vs-Grade 4 |
9.826800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.702000E-01 |
| Normal-vs-ccB subtype |
2.09676720430707E-12 |
| ccA subtype-vs-ccB subtype |
4.15819600974032E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.26250000000028E-05 |
| Normal-vs-N1 |
1.357950E-02 |
| N0-vs-N1 |
2.913600E-01 |
|
|
